UBS Group’s Response Genetics RGDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
– Sell
-16,621
Closed -$5K – 9060
2015
Q2
$5K Buy
16,621
+9,707
+140% +$3.29K ﹤0.01% 7929
2015
Q1
$3K Buy
+6,914
New +$3.08K ﹤0.01% 8399

UBS Group's RGDX Position: Q3 2015 in Review

UBS Group sold out of Response Genetics (RGDX) in Q3 2015, closing a stake of 16,621 shares — an estimated $5K sold.

UBS Group first reported a position in RGDX in Q1 2015 and held it in 2 quarters. The position peaked at $5K in Q2 2015. 1 fund tracked by Wall St. Rank holds RGDX as of Q3 2015.

  • UBS Group reported no remaining Response Genetics position as of Q3 2015 after selling out during the quarter.
  • UBS Group sold 16,621 Response Genetics shares in Q3 2015, an estimated $5K.
  • UBS Group first reported a position in Response Genetics in Q1 2015 and held it in 2 quarters.
  • UBS Group's Response Genetics position peaked at $5K in Q2 2015.
  • 1 fund tracked by Wall St. Rank held Response Genetics as of Q3 2015.

Based on UBS Group's 13F filing for Q3 2015, filed 13 Nov 2015.